$ARIA Recent Headlines Six stocks to watch 4:2
Post# of 72709
Posted On: 06/24/2014 12:56:49 PM
$ARIA Recent Headlines
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape 9:18 a.m. Today - Zacks.com
Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape 8:35 a.m. Today - Zacks.com
Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape 9:46 a.m. June 23, 2014 - Zacks.com
Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape 9:39 a.m. June 23, 2014 - Zacks.com
Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape 9:25 a.m. June 23, 2014 - Zacks.com
Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape 8:57 a.m. June 23, 2014 - Zacks.com
Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape 8:51 a.m. June 23, 2014 - Zacks.com
Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog 5:20 p.m. June 20, 2014 - Zacks.com
Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape 9:18 a.m. June 20, 2014 - Zacks.com
BioLineRx to Commence BL-8040 Study - Analyst Blog 6:10 p.m. June 19, 2014 - Zacks.com
Two Cancer Stocks Take Shots On Goal: Echo He 11:00 a.m. June 19, 2014 - Seeking Alpha
Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape 8:56 a.m. June 19, 2014 - Zacks.com
Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape 8:51 a.m. June 19, 2014 - Zacks.com
Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session - Tale of the Tape 8:30 a.m. June 19, 2014 - Zacks.com
Merck KGaA-Ono Pharma Deal Ends - Analyst Blog 6:15 p.m. June 18, 2014 - Zacks.com
Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog 12:10 p.m. June 18, 2014 - Zacks.com
Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72% - Tale of the Tape 8:44 a.m. June 18, 2014 - Zacks.com
AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% - Tale of the Tape 9:18 a.m. June 17, 2014 - Zacks.com
3 Biotech Stocks Backed By Big Money 1:27 p.m. June 16, 2014 - benzinga.com
WuXi PharmaTech (WX) in Focus: Stock Falls 6.4% - Tale of the Tape 8:59 a.m. June 16, 2014 - Zacks.com
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:00 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:15 p.m. May 31, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences 7:35 a.m. May 28, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:15 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:35 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:35 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:35 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:00 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:12 a.m. April 3, 2014 - ACCESSWIRE
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies 8:00 a.m. April 2, 2014 - PR Newswire - PRF
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer 7:35 a.m. April 2, 2014 - BusinessWire - BZX
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape 9:18 a.m. Today - Zacks.com
Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape 8:35 a.m. Today - Zacks.com
Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape 9:46 a.m. June 23, 2014 - Zacks.com
Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape 9:39 a.m. June 23, 2014 - Zacks.com
Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape 9:25 a.m. June 23, 2014 - Zacks.com
Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape 8:57 a.m. June 23, 2014 - Zacks.com
Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape 8:51 a.m. June 23, 2014 - Zacks.com
Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog 5:20 p.m. June 20, 2014 - Zacks.com
Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape 9:18 a.m. June 20, 2014 - Zacks.com
BioLineRx to Commence BL-8040 Study - Analyst Blog 6:10 p.m. June 19, 2014 - Zacks.com
Two Cancer Stocks Take Shots On Goal: Echo He 11:00 a.m. June 19, 2014 - Seeking Alpha
Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape 8:56 a.m. June 19, 2014 - Zacks.com
Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape 8:51 a.m. June 19, 2014 - Zacks.com
Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session - Tale of the Tape 8:30 a.m. June 19, 2014 - Zacks.com
Merck KGaA-Ono Pharma Deal Ends - Analyst Blog 6:15 p.m. June 18, 2014 - Zacks.com
Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog 12:10 p.m. June 18, 2014 - Zacks.com
Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72% - Tale of the Tape 8:44 a.m. June 18, 2014 - Zacks.com
AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% - Tale of the Tape 9:18 a.m. June 17, 2014 - Zacks.com
3 Biotech Stocks Backed By Big Money 1:27 p.m. June 16, 2014 - benzinga.com
WuXi PharmaTech (WX) in Focus: Stock Falls 6.4% - Tale of the Tape 8:59 a.m. June 16, 2014 - Zacks.com
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:00 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:15 p.m. May 31, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences 7:35 a.m. May 28, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:15 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:35 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:35 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:35 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:00 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:12 a.m. April 3, 2014 - ACCESSWIRE
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies 8:00 a.m. April 2, 2014 - PR Newswire - PRF
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer 7:35 a.m. April 2, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼